---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-043339"
form_type: "8-K"
ticker: "GRDN"
cik: "0001802255"
company_name: "Guardian Pharmacy Services, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T20:08:14.612750+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Guardian Pharmacy reports preliminary Q4 revenue up 20.5% YoY, adj EBITDA up 30.3%; provides FY2025 guidance

## Summary
- Q4 2024 revenue ~$338.6M, +20.5% YoY; net income $10.1-11.1M; adjusted EBITDA ~$25.9M, +30.3% YoY.
- FY2024 revenue ~$1.228B (+17.4% YoY); adjusted EBITDA ~$90.8M (+19.2% YoY); net loss ($71.8M-$72.8M) due to $131.5M IPO-related share-based comp.
- FY2025 guidance: revenue $1.33-1.35B, adjusted EBITDA $97-101M; conference call March 26, 2025.
- Resident count ~186,000 at Q4 end, +14.1% YoY from organic growth and acquisitions.
- Acquisitions of Heartland Pharmacy (Apr 2024) and Freedom Pharmacy (Nov 2024) contributed to growth.

## SEC filing metadata
- accession: 0001193125-25-043339
- form_type: 8-K
- ticker: GRDN
- cik: 0001802255
- company_name: Guardian Pharmacy Services, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802255/000119312525043339/0001193125-25-043339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802255/000119312525043339/d885796d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-043339
- JSON: https://secwatch.observer/filing/0001193125-25-043339.json
- Plain text: https://secwatch.observer/filing/0001193125-25-043339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.